(Q33345288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

H L-Y Chan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

S W-C Tsang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Y Hui

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

N W-Y Leung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

F K-L Chan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

Journal of Viral Hepatitis

14 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

424-428

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00385.X

Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00385.X

Liver transplantation for acute hepatic failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00385.X

Early indicators of prognosis in fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00385.X

Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00385.X

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00385.X

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00385.X

Risk factors for active liver disease in HBeAg-negative chronic hepatitis B virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00385.X

Lamivudine as initial treatment for chronic hepatitis B in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00385.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00385.X

Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00385.X

10.1046/J.1365-2893.2002.00385.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12431204%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference